Follow
'From 2016 to 2017, the largest single-year drop in overall cancer mortality so far — 2.2% — was reported, spurred by rapid declines in lung cancer mortality that have been partially attributed to the approval of immune checkpoint inhibitors (ICIs) and other new targeted therapies'
